补肾序贯结合活血化瘀方治疗子宫内膜异位症所致痛经的临床疗效及对CA125、PGF2α、OT的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

江苏省中医药局科技资助项目(编号:LZ11124)


The clinical efficacy of dysmenorrhea caused by endometriosis and the influence on the sutems as CA125、PGF2α、OT through the treatment of combination of Bushen Xuguan and activing blood circulation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨补肾序贯结合活血化瘀中药对子宫内膜异位症所致痛经的临床疗效及对糖类抗原CA125、前列腺素(PGF2α)、催产素(OT)的影响。方法:将子宫内膜异位症痛经患者随机分成补肾序贯结合活血化瘀中药组(治疗组),中成药活血化瘀组(对照组),其中治疗组50例,对照组30例,观察治疗前后2组患者痛经改善情况,比较治疗前后2组患者血清CA125、PGF2α、OT水平的变化。结果:治疗组治疗痛经总有效率为96%,对照组治疗痛经总有效率为866%,两者总有效率差异有统计学意义(P<005)。2组治疗后痛经程度评分及兼症改善评分均较治疗前差异有统计学意义(P<005),其中治疗组治疗后的兼症评分下降程度与对照组比较差异有统计学意义(P<005);治疗后2组患者血清CA125、PGF2α、OT含量均较治疗前明显下降(P<005),比较治疗组的效果更加明显,其中对CA125及OT水平的影响与对照组比较差异有统计学意义(P<005)。结论:活血化瘀方治疗子宫内膜异位症痛经患者,可以明显改善患者的痛经和兼症症状,降调患者经期血清中CA125、PGF2α、OT等水平,而与补肾序贯法结合使用则疗效更显著,推断中药活血化瘀方治疗内异症的作用机制可能与降调上述指标有关,而补肾序贯中药可能具有免疫调控机制,能够改善痛经患者内分泌环境,不利于异位内膜的黏附,侵袭,从其作用靶点即“源头”上遏制而显疗效。

    Abstract:

    To investigate the clinical efficacy of dysmenorrhea caused by endometriosis and the influence on the sutems as CA125、PGF2α、OT through the treatment of combination of Bushen Xuguan and activing blood circulation.Methods:The choice conforms to this topic diagnosis standard research object 80 examples stochastically divides in to the experimental group 50 examples,the comparison group 30 examples.The experimental group uses Bushen Xuguan and activing blood circulation treatment of Tradition Chinese medicine.The comparison group uses activing blood circulation treatment of Chinese medicine.Improvement of dysmenorrhea and the serums as CA125、PGF2α、OT were tested pretherapy and after treatment.Results:The total efficiency(96%)of experimental group was higher than comparison group(866%),the difference was significant(P<005).The two groups both can lower dysmenorrhea score and Jian Zheng score.Experimental group can effectively lower Jian Zheng sorce superior to comparison group(P<005).The two groups both can lower the serums as CA125、PGF2α、OT.Experimental group can effectively lower the serums as CA125、OT,superior to comparison group(P<005).Conclusion:Treatment of activing blood circulation can extenuate dysmenorrhe and Jian Zheng in Endometriosis patients,lower serums as CA125、PGF2α、OT.However the clinical efficacy of treatment of combination of Bushen Xuguan and activing blood circulation was better than treatment of activing blood circulation。So we can infer that mechanism of TMC was related with lowering the above-mentioned serums.At the same time,we can also infer that treatment of Bushen Xuguan can regulate immunity and endocrine.It is harmful to to adhesion and incursion of ectopic endometrial.Thereby it is a fundamental treatment.

    参考文献
    相似文献
    引证文献
引用本文

孙萃,魏郁清,王淼,张志斌,汤加,周亚红,杨艳琳.补肾序贯结合活血化瘀方治疗子宫内膜异位症所致痛经的临床疗效及对CA125、PGF2α、OT的影响[J].世界中医药,2016,(11).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-02-17
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2016-12-30
  • 出版日期:
文章二维码